血管活性肠肽测量在鉴别韦纳-莫里森综合征和假性韦纳-莫里森综合征中的应用
VIP measurement in distinguishing Verner-Morrison syndrome and pseudo Verner-Morrison syndrome.
作者信息
Bloom S R, Polak J M
出版信息
Clin Endocrinol (Oxf). 1976;5 Suppl:223S-228S. doi: 10.1111/j.1365-2265.1976.tb03831.x.
Abstract
- Plasma VIP immunoreactivity is always diagnostically raised in patients with pancreatic tumour causing the Verner-Morrison syndrome. 2. Human tumour VIP is physico-chemically similar to porcine VIP. 3. The only other situation in which plasma VIP is very elevated is in patients with ganglioneuroblastomas associated with diarrhoea. 4. VIP is not elevated in patients with diarrhoea associated with pancreatic islet hyperplasia, designated the pseudo Verner-Morrison syndrome.
摘要
- 患有导致韦纳-莫里森综合征的胰腺肿瘤患者的血浆血管活性肠肽免疫反应性在诊断上总是升高的。2. 人肿瘤血管活性肠肽在物理化学性质上与猪血管活性肠肽相似。3. 血浆血管活性肠肽非常升高的唯一其他情况是患有与腹泻相关的神经节神经母细胞瘤的患者。4. 患有与胰岛增生相关的腹泻（称为假性韦纳-莫里森综合征）的患者中血管活性肠肽不升高。
Zotero 插件